Novel agents for cutaneous T-cell lymphoma

Timothy M. Kuzel; Richard Junghans; Francine M. Foss

doi:10.1016/S0889-8588(03)00112-6

Novel agents for cutaneous T-cell lymphoma

Timothy M. Kuzel, Richard Junghans, Francine M. Foss^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Several novel therapies have recently emerged for the treatment of hematologic malignancies; several agents have demonstrated activity against T-cell lymphomas in vitro or in early clinical trials. This article discusses how these therapies may be implemented in the treatment of patients who have advanced or refractory cutaneous T-cell lymphoma.

Original language	English (US)
Pages (from-to)	1459-1466
Number of pages	8
Journal	Hematology/Oncology Clinics of North America
Volume	17
Issue number	6
DOIs	https://doi.org/10.1016/S0889-8588(03)00112-6
State	Published - Dec 2003

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1016/S0889-8588(03)00112-6

Cite this

@article{0d6d7a5e80f34c89b97fdfa977441cf8,

title = "Novel agents for cutaneous T-cell lymphoma",

abstract = "Several novel therapies have recently emerged for the treatment of hematologic malignancies; several agents have demonstrated activity against T-cell lymphomas in vitro or in early clinical trials. This article discusses how these therapies may be implemented in the treatment of patients who have advanced or refractory cutaneous T-cell lymphoma.",

author = "Kuzel, {Timothy M.} and Richard Junghans and Foss, {Francine M.}",

year = "2003",

month = dec,

doi = "10.1016/S0889-8588(03)00112-6",

language = "English (US)",

volume = "17",

pages = "1459--1466",

journal = "Hematology/Oncology Clinics of North America",

issn = "0889-8588",

publisher = "W.B. Saunders Ltd",

number = "6",

}

TY - JOUR

T1 - Novel agents for cutaneous T-cell lymphoma

AU - Kuzel, Timothy M.

AU - Junghans, Richard

AU - Foss, Francine M.

PY - 2003/12

Y1 - 2003/12

N2 - Several novel therapies have recently emerged for the treatment of hematologic malignancies; several agents have demonstrated activity against T-cell lymphomas in vitro or in early clinical trials. This article discusses how these therapies may be implemented in the treatment of patients who have advanced or refractory cutaneous T-cell lymphoma.

AB - Several novel therapies have recently emerged for the treatment of hematologic malignancies; several agents have demonstrated activity against T-cell lymphomas in vitro or in early clinical trials. This article discusses how these therapies may be implemented in the treatment of patients who have advanced or refractory cutaneous T-cell lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=0346367058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346367058&partnerID=8YFLogxK

U2 - 10.1016/S0889-8588(03)00112-6

DO - 10.1016/S0889-8588(03)00112-6

M3 - Review article

C2 - 14710896

AN - SCOPUS:0346367058

SN - 0889-8588

VL - 17

SP - 1459

EP - 1466

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

IS - 6

ER -

Novel agents for cutaneous T-cell lymphoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this